Infectious Disease
-
Case discussions to address complexities of mediastinal lymphadenopathy diagnosis
Sebastian Kurz, MD, PhD, FCCP, will chair a Wednesday afternoon panel session that will guide attendees through imaging findings, differential diagnoses, and clinical decision-making in mediastinal lymphadenopathy.
-
Experts discuss advances in understanding, management of chronic cough
Sumera Ahmad, MBBS, discussed pharmacological innovations for chronic cough, including P2X3 antagonists, opiates, and neuromodulators.
-
90th anniversary sessions to reflect on past, present, and future of field
Nichole T. Tanner, MD, MSCR, FCCP, and five other CHEST experts will chair special sessions about 90 years of progress in mechanical ventilation, TB, lung cancer, diffuse lung disease, respiratory vaccines, and asthma.
-
Session to review latest science, recommendations for vaccines against respiratory infections
Charles Dela Cruz, MD, PhD, will chair a Sunday afternoon session on current practice recommendations for COVID-19, influenza, RSV, and pneumococcal vaccines.
-
Azelastine nasal spray shows promise in preventing SARS-CoV-2 infections
Researcher Robert Bals, MD, PhD, said this is a starting point, a signal of efficacy that warrants confirmation in larger, multicentric, phase 3 trials.
-
Session to outline strategies for emerging pathogen preparedness
Kevin Swiatek, DO, FCCP, will chair a session addressing obstacles to and opportunities for a comprehensive response to emerging pathogens in the United States.
-
Moderate to severe OSA increases risk of severe COVID-19
According to critical care specialist Lina Miyakawa, MD, FCCP, the findings are a reminder that OSA “is not just a sleep disorder but a systemic condition with meaningful public health implications.”
-
Oseltamivir beats supportive care for patients hospitalized with seasonal influenza
Investigator Anthony Bai, MD, MSc, and infectious disease expert Christina Thornton, MD, PhD, discuss a large analysis that showed an in-hospital mortality rate of 3.5% for oseltamivir vs 4.9% for supportive care.
-
EHR data confirm effectiveness of RSV vaccine in adults aged 60 and older
Pauline Terebuh, MD, MPH, said the results aligned with previous trials; however, Shaun J. Grannis, MD, said more data are needed to determine the durability of the protection.
-
Data support early prone positioning for patients with COVID-19 on mechanical ventilation
Viren Kaul, MD, FCCP, said a recent observational study adds to the body of literature clarifying the optimal timing of prone positioning in this population.
